Case Study: Pathan B.V predicts neoadjuvant chemotherapy response with Aiforia Create

A Aiforia Case Study

Preview of the Pathan B.V Case Study

Pathan B.V predicts chemotherapy response with Aiforia using 0.696 AUC

Pathan B.V., in collaboration with Radboud University Medical Center, sought to predict the outcome of neoadjuvant chemotherapy for triple-negative breast cancer patients. The challenge was to accurately determine which patients would respond well to this pre-operative treatment, thereby preventing unnecessary toxic side effects and treatment delays for those who would not benefit.

Using Aiforia's cloud-based platform, Aiforia Create, the team developed a deep learning AI model trained on annotated whole-slide images of biopsy samples. The solution developed by Aiforia achieved a predictive AUC ROC score of 0.696 on a test set, outperforming traditional clinical data methods. This demonstrates AI's capability to extract subtle predictive visual data, which can alleviate pathologists' workloads, decrease healthcare costs, and lead to safer, more efficient treatment decisions.


View this case study…

Aiforia

51 Case Studies